High-level autophagy results in cancer cell survival and resistance to FLT-TKIs.343 In erlotinib-resistant NSCLC, high GATA binding protein 6 (GATA6) and a threefold increase in autophagic activity were observed. The gene discussed is GATA6; the disease is cancer.